BioCentury
ARTICLE | Clinical News

Paclical micellular paclitaxel: Interim Phase III data

August 8, 2011 7:00 AM UTC

Interim data from about 400 patients in an ongoing, open-label, European Phase III trial showed that 250 mg/m 2 Paclical given as a 1-hour infusion plus carboplatin on day 1 of each 21-day cycle reduc...